REFERENCES
- Zusman R. M. Alternatives to Traditional Antihypertensive Therapy. Hypertension 1986; 8: 837–842
- Rutledge D. R., Abadi A. H., Lopez L. M., Beaudreau C. A. High-Performance Liquid Chromatographic Determination of Diltiazem and Two of Its Metabolites in Plasma Using a Short Alkyl Chain Deactivated Column. J. Chromatogr. 1993; 615: 111–116
- Yeung P. K.F., Montague T. J., Tsui B., Mc Gregor C. High-Performance Liquid Chromatographic Assay of Diltiazem and Six of Its Metabolites In Plasma: Application to a Pharmacokinetic Study in Healthy Volunteers. J. Pharm. Sci. 1989; 78: 592–597
- Hoglund P., Nilsson L. G. Liquid Chromatographic Determination of Diltiazem and Its Metabolites Using Trans Isomers as Internal Standards, with Dynamic Modification of the Solid Phase by Addition an Amine to the Mobile Phase. J. Chromatogr. 1987; 414: 109–120
- Bianchetti G., Regazzi M., Rondanelli R., Ascalone V., Morselli P. L. Bioavailability of Diltiazem as a Function of the Administered Dose. Biopharm. Drug Dispos. 1991; 12: 391–401
- Volonté M. G., Quiroga P., Yuln G., Palummo M., Cingolani A. Metodología Analítica por HPLC Aplicada al Monitoreo de Diltiazem en Plasma. Rev. Farm. 1999; 141: 7–12
- Dall L. L., Arenoso H. J., Soutric J. L., Rimada R. S. Análisis Farmacocinético de una Nueva Forma Farmacéutica de Diltiazem. J. Prensa Med. Argent. 1986; 73: 85–89
- Pollola J. A., Martire V., Rimada R., Dall L., Soutric J. Niveles Plasmaticos de Diltiazem A.P. en Pacientes Cardiopatas de 3era. Edad en Tratamiento Continuo. 15th Congreso Argentino de Cardiologia. Buenos Aires 1987; 333
- U.S. Pharmacopeial Convention. The United States Pharmacopoeia 23. Suppl. 5, U.S. Pharmacopeial Convention, Rockville, MD 1996; 3410
- Khan K. A. The Concept of Dissolution Efficiency. J. Pharm. Pharm. 1975; 27: 48–49
- Brockmeier D. In Vitro/In Vivo Correlation of Dissolution Using Moments of Dissolution and Transit Times. Acta Pharm. Technol. 1986; 32: 164–174
- Endrenyi L., Fritsch S., Fritsch W. Cmax/AUC Is a Clearer Measure than Cmax for Absorption Rates in Investigations of Bioequivalence. Int. J. Clin. Pharmacol. Ther. Toxicol. 1991; 29: 394–399
- Endrenyi L., Yan W. Variations of Cmax and Cmax/AUC in Investigations of Bioequivalence. Int. J. Clin. Pharmacol. Ther. Toxicol. 1993; 31: 184–189
- Cefali E. A., Banfield C. R., González M. A., Wagner J. G. In Vivo Determination of Zero-Order Absorption from a Transdermal Glycerol Trinitrate System. Eur. J. Pharm. Biopharm. 1993; 39: 140–143
- Khoo K. C., Gibaldi M., Brazzell R. K. Comparison of Statistical Moment Parameters to Cmax and tmax for Detecting Differences in In Vivo Dissolution Rates. J. Pharm. Sci. 1985; 74: 1340–1342
- Riegelman S., Collier P. The Application of Statistical Moment Theory to the Evaluation of In Vivo Dissolution Time and Absorption Time. J. Pharmacokin. Biopharm. 1980; 8: 509–533
- Steinijans V. W., Diletti E. Statistical Design and Evaluation of Tests for Bioavailability. Acta Pharm. Technol. 1983; 29: 147–158
- Wagner J. G., Nelson E. Kinetic Analysis of Blood Levels and Urinary Excretion in the Absorptive Phase After Single Doses of Drug. J. Pharm. Sci. 1964; 53: 1392–1403